Funded Tech Companies
True North Therapeutics
Wondering who bought True North Therapeutics? The company was acquired by Bioverativ.
Company Overview
Company Name
True North Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
951 Gateway Blvd.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases of high unmet clinical need. The company's lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition of downstream phagocytosis, inflammation, and cell lysis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/26/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nancy Stagliano
Chief Financial Officer
Pamela Wapnick
Chief Medical Officer
Gary Patou
VP - Bus. Development
Adam Rosenthal
VP - R & D
Graham Parry
Company Investors
- HBM Healthcare Investments (Andreas Wicki)
- Perceptive Advisors
- Redmile Group (Michael Lee)
- Franklin Templeton
- SR One Capital Management (Rajeev Dadoo)
- Baxalta Ventures (Geeta Vemuri)
- OrbiMed (Carl Gordon)
- New Leaf Venture Partners (Isaac Manke)
- Cowen Capital Partners
- MPM Capital (James Scopa)
- Kleiner Perkins Caufield & Byers (Beth Seidenberg)
- Baxter Ventures (Geeta Vemuri)
- Biogen Idec
Browse more funded tech companies:
True Link Financial | True Office
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs